References
- Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413–420.
- Hörter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev 1997; 25:3–14.
- Spireas S, Bolton SM Liquisolid systems and methods of preparing same. US Patent 1998; 5968:550.
- Sheth A, Jarowski CI. Use of powdered solutions to improve the dissolution rate of polythiazide tablets. Drug Dev Ind Pharm 1990; 16:769–777.
- Spireas S, Sadu S. Enhancement of prednisolone dissolution properties using liquisolid compacts. Int J Pharm 1998; 166:177–188.
- Spireas S, Sadu S, Grover R. In vitro release evaluation of hydrocortisone liquisolid tablets. J Pharm Sci 2000;87:867–872.
- Fahmy RH, Kassem MA. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation. Eur J Pharm Biopharm 2008;69:993–1003.
- Tiong N, Elkordy AA. Effects of liquisolid formulations on dissolution of naproxen. Eur J Pharm Biopharm 2009;73:373–384.
- Javadzadeh Y, Jafari-Navimipour B, Nokhodchi A. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Int J Pharm 2007;341:26–34.
- Javadzadeh Y, Siahi-Shadbad MR, Barzegar-Jalali M, Nokhodchi A. Enhancement of dissolution rate of piroxicam using liquisolid compacts. Farmaco 2005;60:361–365.
- Nokhodchi A, Javadzadeh Y, Siahi-Shadbad MR, Barzegar-Jalali M. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. J Pharm Pharm Sci 2005; 8:18–25.
- Spireas S, Wang T, Grover R. Effect of powder substrate on the dissolution properties of methyclothiazide liquisolid compacts. Drug Dev Ind Pharm 1999;25:163–168.
- Patel R, Bhimani D, Patel J, Patel D. Solid-state characterization and dissolution properties of ezetimibe–cyclodextrins inclusion complexes. J Incl Phen Macr Chem 2008; 60:241–251.
- Doney JA, et al. Brzeczko AW, et al. Amorphous ezetimibe and the production thereof. US patent, 2006, 20080085315.
- Sancheti PP, Karekar P, Vyas VM, Shah M, Pore YV. Preparation and physicochemical characterization of surfactant based solid dispersions of ezetimibe. Pharmazie 2009;64:227–231.
- Dixit RP, Nagarsenker MS. Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation. Eur J Pharm Sci 2008;35:183–192.
- Yadav VB. Enahncement of solubility and dissolution rate of bcs class II pharmaceuticals by non aques granulation technique. Int J Pharm Res Dev 2010; 1:1–12.
- Rowe RC, Sheskey PJ, Owen SC. American Pharmacists Association Handbook of pharmaceutical excipients,2006,132–191.
- Lerk CF, Bolhuis GK, de Boer AH. Effect of microcrystalline cellulose on liquid penetration in and disintegration of directly compressed tablets. J Pharm Sci 1979;68:205–211.